Suzetrigine vs Norco-postoperative Mohs Pain

NCT07575230 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Tumors
Mohs Micrographic Surgery

Interventions

DRUG: Norco 5Mg-325Mg Tablet
DRUG: Suzetrigine

Sponsor

Baylor Research Institute